Evidence map›Paper›PMID 42653161›Full record

ReviewInternational journal of molecular sciences2026

Convergent Mechanistic Pathways Driving the Anaplastic Phenotype in Thyroid Cancer.

Anthony Centone, Nicole R DeSouza, Nan Yang, Shaun Desai, Augustine Moscatello, David Garber, Steven Hemmerdinger, Janine M Rotsides, Mike Yao, Raj K Tiwari and 2 more

Abstract readReview
In one paragraph

Review in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Anthony CentoneDepartment of Pathology, Microbiology & Immunology, New York Medical College, Valhalla, NY 10595, USA.ORCID 0009-0000-7630-5001
Nicole R DeSouzaDepartment of Pathology, Microbiology & Immunology, New York Medical College, Valhalla, NY 10595, USA.
Nan YangDivision of R&D, General Nutraceutical Technology, LLC., Briarcliff Manor, NY 10510, USA.
Shaun DesaiDepartment of Otolaryngology, New York Medical College, Valhalla, NY 10595, USA.
Augustine MoscatelloDepartment of Otolaryngology, New York Medical College, Valhalla, NY 10595, USA.
David GarberDepartment of Otolaryngology, New York Medical College, Valhalla, NY 10595, USA.ORCID 0000-0001-9309-1535
Steven HemmerdingerDepartment of Otolaryngology, New York Medical College, Valhalla, NY 10595, USA.
Janine M RotsidesDepartment of Otolaryngology, New York Medical College, Valhalla, NY 10595, USA.
Mike YaoDepartment of Otolaryngology, New York Medical College, Valhalla, NY 10595, USA.
Raj K TiwariDepartment of Pathology, Microbiology & Immunology, New York Medical College, Valhalla, NY 10595, USA.
Jan GeliebterDepartment of Pathology, Microbiology & Immunology, New York Medical College, Valhalla, NY 10595, USA.ORCID 0000-0002-2944-7960
Xiu-Min LiDepartment of Pathology, Microbiology & Immunology, New York Medical College, Valhalla, NY 10595, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Anaplastic thyroid carcinoma (ATC) is a rare, highly aggressive follicular cell-derived malignancy characterized by rapid progression, profound dedifferentiation, and marked resistance to conventional therapy. Despite frequent involvement of major oncogenic pathways, ATC does not exhibit a universal driver mutation, suggesting that its pathogenesis reflects convergence upon shared biological hallmarks rather than dependence on a single molecular event. This review describes the principal mechanistic programs that define the ATC phenotype: disruption of cell-cycle and apoptotic control through alterations in

Indexed as

Thyroid Carcinoma, AnaplasticThyroid NeoplasmsAnimalsEndoplasmic Reticulum StressHumansMetabolic ReprogrammingPhenotypeSignal TransductionTumor Microenvironmentanaplastic thyroid cancerER stresshypoxia signalingmetabolic reprogrammingtumor microenvironment

Identifiers

PMID42653161
PMCPMC13513259

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.